These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 26088390)
1. Therapeutic developments in the therapy of heart failure: lessons to be learned. Parker JD Eur Heart J; 2015 Aug; 36(30):1952-4. PubMed ID: 26088390 [No Abstract] [Full Text] [Related]
2. Heart failure: another new PARADIGM in treatment for heart failure? Geach T Nat Rev Cardiol; 2015 Jan; 12(1):4. PubMed ID: 25445135 [No Abstract] [Full Text] [Related]
3. Efficacy of angiotensin-neprilysin inhibition versus enalapril in patient with heart failure with a reduced ejection fraction. Ferrari L; Sada S; Intern Emerg Med; 2015 Apr; 10(3):369-71. PubMed ID: 25537439 [No Abstract] [Full Text] [Related]
4. PARADIGM-HF--the experts' discussion. Jessup M; Fox KA; Komajda M; McMurray JJ; Packer M N Engl J Med; 2014 Sep; 371(11):e15. PubMed ID: 25184757 [No Abstract] [Full Text] [Related]
5. Prospective Comparison of ARNi with ACE-I to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF): paragon of a study or further investigation paramount? Krum H Circulation; 2015 Jan; 131(1):11-2. PubMed ID: 25411157 [No Abstract] [Full Text] [Related]
17. Neprilysin Inhibition and the Treatment of Heart Failure: Recent Steps in the Right Direction. Bartell N; Frishman WH Cardiol Rev; 2017; 25(6):315-320. PubMed ID: 28984670 [TBL] [Abstract][Full Text] [Related]